Oncternal Provides Business Update and Announces First Quarter 2021 Financial Results
Interim results of a Phase 1b trial of cirmtuz umab and paclitaxel in locally advanced/unresectable or metastatic HER2-negative breast...
Search
- May 6, 2021
Nabriva Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates
- First quarter of full complement of 60 sales representatives further expanding the reach of XENLETA® (lefamulin) and SIVEXTRO®...
- Apr 27, 2021
Equillium Announces Three Abstracts Accepted for Presentation at the 104th AAI Annual Meeting
Presentations highlight the pathogenic role of the CD6-ALCAM pathway, the immunologic impact of modulating this pathway with itolizumab,...
- Mar 25, 2021
MatriSys Bioscience Names Joyce Rico as Chief Medical Officer
MatriSys Bioscience, a company harnessing beneficial bacteria to treat inflammatory skin diseases, today announced the hiring of Joyce...
- Mar 23, 2021
ALASTIN Skincare® Named to Forbes America’s Best Startup Employers 2021 List
ALASTIN Skincare®, Inc., a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested...